SUNRISE-II feasibility trial marks the company’s entry into U.S. clinical development, advancing minimally invasive, anesthesia-free treatment approach ...
Next generation mitral valve, designed to facilitate patient lifetime management reports first uses in sternotomy, Minimally ...
Edwards announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained ...
Having already set expectations around the structured capture of medical device safety data, regulators are now ready to analyze related insights, and they expect device manufacturers to match this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results